Pure Global
CDSCO UID MFG/IVD/2019/000001_969eae3ab7a8a5b81777e6c1b0e153f0_ccf91c32b09ad527a607e9b4a2fcaa59

Anticyclic Citrullinated Proteins Rapid Test

Diabetomics Medical (P) Ltd·Device Class Class B·India CDSCO·Brand: Lumella
Registration details
UID
MFG/IVD/2019/000001_969eae3ab7a8a5b81777e6c1b0e153f0_ccf91c32b09ad527a607e9b4a2fcaa59
Device class
Class B
Brand name
Lumella
License holder
Diabetomics Medical (P) Ltd
Approving authority
Telangana
Product information
Anticyclic Citrullinated Proteins (Lumella) test kit is a lateral flow immunoassay intended to be used for as an aid to diagnosis by qualitative detection of IgG antibodies to Citrullinated Proteins in serum from patients suspected of Rheumatoid arthritis.
Similar products (3)
Other products with the same name or brand
C-Peptide Testing Kit
Brand: Lumella
Diabetomics Medical (P) Ltd
Class B
Glutamic Acid Decarboxylase Test
Brand: Lumella
Diabetomics Medical (P) Ltd
Class B
Preeclampsia Test System
Brand: Lumella
Diabetomics Medical (P) Ltd
Class B
Other products from Diabetomics Medical (P) Ltd
Products from the same license holder (4 products)
SARS-CoV-2 Antibody Test
Brand: CovAbScreen / CovAb
Class C
C-Peptide Testing Kit
Brand: Lumella
Class B
Glutamic Acid Decarboxylase Test
Brand: Lumella
Class B
Preeclampsia Test System
Brand: Lumella
Class B
About this record

Anticyclic Citrullinated Proteins Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2019/000001_969eae3ab7a8a5b81777e6c1b0e153f0_ccf91c32b09ad527a607e9b4a2fcaa59. This device is marketed under the brand name Lumella. The license holder is Diabetomics Medical (P) Ltd, and it is classified as Device Class Class B. The approving authority is Telangana.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.